This elderly population is a high-risk, problem-prone group that often has multiple comorbidities requiring a comprehensive and caring approach in management to prevent disease and disability. It is also relevant to discuss this population subset because the elderly are the fastest growing demographic subgroup in the U.S. population.
In 2000, 40% of all deaths in Americans over the age of 65 were linked to hyperlipidemia. Coronary artery disease mortality and morbidity are highest among elderly men and women, with more than 80% of the deaths from coronary heart disease (CHD) occurring in individuals over the age of 65 . Reducing the death or resultant disability related to these conditions is of obvious importance and benefit to individual patients and to our nation.
Pharmacologic therapy for hyperlipidemia in elderly patients is expensive for those seniors on limited incomes or with significant drug cost shares. The number of medications and multiple comorbidities common in...
KeywordsStatin Therapy Anabolic Steroid Elite Athlete Bile Acid Sequestrant High Density Lipoprotein Level
- 2.Merck Institute of Aging and Health. The state of aging and health in America 2004. Washington, DC: Merck Institute of Aging and Health (MIAH), 2004:1.Google Scholar
- 3.Katzel LI, Goldberg AP. Dyslipoproteinemia. In: Hazzard WR, Blass JP, Ettinger WH, et al. (eds) Principles of geriatric medicine and gerontology, 4th edn. New York: McGraw-Hill, 1999:1013–1028.Google Scholar
- 4.Beck L. Aging changes in renal function. In: Hazzard WR, Blass JP, Ettinger WH, et al. (eds) Principles of geriatric medicine and gerontology, 4th edn. New York: McGraw-Hill, 1999.Google Scholar
- 7.Fouts M, Hanlon J, Pieper C, et al. Identification of elderly nursing home residents at high risk for drug related problems. Consult Pharmacol 1997;12:1103–1111.Google Scholar
- 14.Colhoun HM, Betteridge DJ, Durrington PN, et al., on behalf of the CARDS Investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685–696.PubMedCrossRefGoogle Scholar
- 18.American Heart Association. Heart Disease and Stroke Statistics: 2005 Update. http://www.americanheart.org/presenter.jhtml?identifier=3000090. Accessed 07/07/06.
- 21.Anonymous. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990;264:3018–3024.Google Scholar
- 25.NCEP. Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:495–501.Google Scholar
- 30.Howard BV, Lee ET, Cown LD, et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 1999;99:2389–2395.Google Scholar
- 33.Wood P, Williams PT, Haskell WL. Physical activity and high density lipoproteins. In: Miller NE, Miller GJ (eds) Clinical and metabolic aspects of high density lipoproteins. Amsterdam: Elsevier, 1984:133–165.Google Scholar
- 38.Crouse JR III, Elam MB, Robinson JG, et al. Cholesterol management: targeting a lower low density lipoprotein cholesterol concentration increases ATP-III goal attainment. Am J Cardiol 2006;97(11):1667–1669.Google Scholar